Fig. 8: Schematic representation of BCMA-BTZ-NPs in MM.

BCMA-BTZ-NPs can trigger apoptosis, improve immunogenic cell death, potentiate therapeutic efficacy even in PgP-mediated resistant cells, and demonstrate tumor-specific accumulation and cytotoxicity.